Go Pro

Marqeta (MQ) Financials

Marqeta logo
$16.33 +0.17 (+1.05%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$16.32 0.00 (-0.03%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Marqeta

Annual Income Statements for Marqeta

This table shows Marqeta's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-122 -48 -164 -185 -223 27 -14
Consolidated Net Income / (Loss)
-58 -48 -164 -185 -223 27 -14
Net Income / (Loss) Continuing Operations
-58 -48 -164 -185 -223 27 -14
Total Pre-Tax Income
-58 -48 -165 -185 -231 28 -13
Total Operating Income
-59 -47 -162 -210 -283 -24 -46
Total Gross Profit
60 118 232 320 330 352 437
Total Revenue
143 290 517 748 676 507 625
Operating Revenue
143 290 517 748 676 507 625
Total Cost of Revenue
83 172 285 428 793 553 188
Operating Cost of Revenue
83 172 285 428 793 553 188
Total Operating Expenses
119 165 394 530 166 -21 484
Selling, General & Admin Expense
22 155 66 102 95 97 107
Marketing Expense
2.08 1.67 2.28 4.00 2.57 2.99 5.07
Depreciation Expense
3.08 3.50 3.53 3.85 11 17 27
Other Operating Expenses / (Income)
92 4.34 322 420 58 -139 344
Total Other Income / (Expense), net
0.70 -0.52 -2.56 25 52 53 33
Other Income / (Expense), net
0.70 -0.52 -2.56 25 52 53 33
Income Tax Expense
0.04 0.09 -0.64 -0.10 -7.61 0.79 0.60
Weighted Average Basic Shares Outstanding
113.85M 122.93M 362.76M 545.40M 532.54M 511.07M 462.17M
Weighted Average Diluted Shares Outstanding
113.85M 122.93M 362.76M 545.40M 532.54M 518.85M 462.17M
Weighted Average Basic & Diluted Shares Outstanding
- - 542.80M 538.58M 513.81M 504.32M 427.21M

Quarterly Income Statements for Marqeta

This table shows Marqeta's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-40 -36 119 -29 -27 -8.26 -0.65 -3.62 -1.39 7.83 7.57
Consolidated Net Income / (Loss)
-40 -36 119 -29 -27 -8.26 -0.65 -3.62 -1.39 7.83 7.57
Net Income / (Loss) Continuing Operations
-40 -36 119 -29 -27 -8.26 -0.65 -3.62 -1.39 7.83 7.57
Total Pre-Tax Income
-41 -36 119 -29 -27 -8.03 -0.44 -3.13 -1.74 8.03 8.07
Total Operating Income
-56 -50 105 -42 -37 -19 -9.23 -10 -8.29 2.09 3.64
Total Gross Profit
83 84 79 90 98 99 104 115 120 118 122
Total Revenue
119 118 125 128 136 139 150 163 172 166 176
Operating Revenue
119 118 125 128 136 139 150 163 172 166 176
Total Cost of Revenue
-78 34 149 38 -66 40 46 49 52 48 54
Operating Cost of Revenue
-78 34 149 38 -66 40 46 49 52 48 54
Total Operating Expenses
253 134 -129 132 239 117 113 125 128 115 118
Selling, General & Admin Expense
25 21 23 25 28 24 24 31 28 26 29
Marketing Expense
1.22 0.38 0.73 0.58 1.30 0.47 0.71 0.90 3.00 1.16 1.23
Depreciation Expense
3.16 3.54 3.96 4.45 5.52 5.33 6.65 7.02 8.16 8.85 9.70
Other Operating Expenses / (Income)
224 109 -157 102 204 87 82 86 89 79 79
Total Other Income / (Expense), net
15 14 14 14 11 11 8.79 7.24 6.56 5.93 4.44
Other Income / (Expense), net
15 14 14 14 11 11 8.79 7.24 6.56 5.93 4.44
Income Tax Expense
-1.03 0.13 0.15 0.12 0.39 0.24 0.21 0.50 -0.34 0.19 0.51
Weighted Average Basic Shares Outstanding
532.54M 517.99M 515.96M 507.16M 511.07M 501.22M 115.38M 448.72M 462.17M 428.60M 105.47M
Weighted Average Diluted Shares Outstanding
532.54M 517.99M 524.40M 507.16M 518.85M 501.22M 115.38M 448.72M 462.17M 433.57M 106.80M
Weighted Average Basic & Diluted Shares Outstanding
513.81M 518.11M 508.37M 502.39M 504.32M 468.27M 448.23M 440.10M 427.21M 424.03M 104.10M

Annual Cash Flow Statements for Marqeta

This table details how cash moves in and out of Marqeta's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
23 160 1,027 -64 -202 -58 86
Net Cash From Operating Activities
-15 50 57 -13 21 58 163
Net Cash From Continuing Operating Activities
-15 50 57 -13 21 58 163
Net Income / (Loss) Continuing Operations
-58 -48 -164 -185 -223 27 -14
Consolidated Net Income / (Loss)
-58 -48 -164 -185 -223 27 -14
Depreciation Expense
3.08 3.50 3.53 3.85 11 17 27
Amortization Expense
-0.50 0.54 1.16 0.28 -4.50 -3.23 -0.76
Non-Cash Adjustments To Reconcile Net Income
39 78 192 172 236 29 137
Changes in Operating Assets and Liabilities, net
0.95 16 24 -3.97 1.83 -12 13
Net Cash From Investing Activities
-100 -58 -329 29 39 71 271
Net Cash From Continuing Investing Activities
-100 -58 -329 29 39 71 271
Purchase of Property, Plant & Equipment
-4.91 -2.38 -2.74 -2.32 -13 -21 -30
Acquisitions
-0.75 0.00 -20 -1.60 -136 0.00 -46
Purchase of Investments
-528 -216 -455 -70 -892 0.00 -3.50
Sale and/or Maturity of Investments
434 161 149 77 1,079 92 121
Other Investing Activities, net
- - - 0.00 -0.09 0.00 230
Net Cash From Financing Activities
139 167 1,299 -79 -262 -187 -347
Net Cash From Continuing Financing Activities
139 167 1,299 -79 -262 -187 -347
Repurchase of Common Equity
0.00 -2.71 -4.76 -78 -190 -154 -391
Issuance of Common Equity
0.00 0.00 1,323 4.76 3.07 2.72 2.10
Other Financing Activities, net
1.06 3.14 -19 -6.11 -74 -35 42
Cash Income Taxes Paid
- - 0.20 0.08 0.43 0.40 0.60

Quarterly Cash Flow Statements for Marqeta

This table details how cash moves in and out of Marqeta's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
34 -11 -46 -38 37 -92 -98 241 35 -62 -2.02
Net Cash From Operating Activities
17 0.43 26 7.28 25 9.99 13 87 53 -3.37 63
Net Cash From Continuing Operating Activities
17 0.43 26 7.28 25 9.99 13 87 53 -3.37 63
Net Income / (Loss) Continuing Operations
-40 -36 119 -29 -27 -8.26 -0.65 -3.62 -1.39 7.83 7.57
Consolidated Net Income / (Loss)
-40 -36 119 -29 -27 -8.26 -0.65 -3.62 -1.39 7.83 7.57
Depreciation Expense
3.16 3.54 3.96 4.45 5.52 5.33 6.65 7.02 8.16 8.85 9.70
Amortization Expense
1.03 -0.98 -0.85 -0.83 -0.58 -0.40 -0.22 -0.08 -0.06 -0.03 -0.01
Non-Cash Adjustments To Reconcile Net Income
62 55 -127 43 57 45 18 36 39 41 0.74
Changes in Operating Assets and Liabilities, net
-9.39 -21 30 -11 -10 -31 -11 48 7.66 -61 45
Net Cash From Investing Activities
82 34 -6.17 9.71 34 15 61 183 13 16 19
Net Cash From Continuing Investing Activities
82 34 -6.17 9.71 34 15 61 183 13 16 19
Purchase of Property, Plant & Equipment
-2.44 -6.50 -6.17 -4.30 -4.25 -7.33 -7.87 -8.26 -6.80 -9.08 -8.56
Sale and/or Maturity of Investments
4.52 40 - 14 38 22 69 9.24 21 25 28
Net Cash From Financing Activities
-65 -45 -65 -55 -22 -117 -172 -28 -31 -75 -84
Net Cash From Continuing Financing Activities
-65 -45 -65 -55 -22 -117 -172 -28 -31 -75 -84
Repurchase of Common Equity
-59 -34 -57 -47 -17 -111 -164 -20 -97 -39 -55
Other Financing Activities, net
-6.90 -11 -9.31 -8.74 -6.28 -5.66 -8.65 -8.29 65 -35 -31

Annual Balance Sheets for Marqeta

This table presents Marqeta's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
458 1,830 1,770 1,590 1,463 1,525
Total Current Assets
431 1,799 1,747 1,389 1,249 1,235
Cash & Equivalents
220 1,248 1,184 981 923 709
Restricted Cash
7.80 7.80 7.80 8.50 8.50 308
Short-Term Investments
150 453 441 269 179 62
Accounts Receivable
28 44 58 73 97 102
Prepaid Expenses
11 36 38 27 25 35
Other Current Assets
13 11 18 30 16 18
Plant, Property, & Equipment, net
9.48 9.69 7.44 19 38 60
Total Noncurrent Assets
17 22 16 182 176 230
Goodwill
- - 0.00 124 124 155
Intangible Assets
- - 0.00 36 30 51
Other Noncurrent Operating Assets
17 14 16 23 23 24
Total Liabilities & Shareholders' Equity
458 1,830 1,770 1,590 1,463 1,525
Total Liabilities
170 257 297 346 378 763
Total Current Liabilities
141 238 283 337 371 749
Accounts Payable
2.36 2.69 3.80 1.42 0.53 1.85
Accrued Expenses
139 235 279 335 370 440
Other Current Liabilities
- - - - 0.00 307
Total Noncurrent Liabilities
28 19 15 9.72 7.20 14
Other Noncurrent Operating Liabilities
28 19 15 9.72 7.20 14
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-214 1,573 1,473 1,243 1,085 762
Total Preferred & Common Equity
-214 1,573 1,473 1,243 1,085 762
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-214 1,573 1,473 1,243 1,085 762
Common Stock
40 1,993 2,082 2,068 1,883 1,572
Retained Earnings
-254 -417 -602 -825 -798 -812
Accumulated Other Comprehensive Income / (Loss)
0.03 -2.23 -7.24 0.76 -0.31 1.51

Quarterly Balance Sheets for Marqeta

This table presents Marqeta's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
1,774 1,704 1,603 1,558 1,488 1,436 1,350 1,215 1,488 1,477 1,392
Total Current Assets
1,585 1,514 1,407 1,348 1,273 1,221 1,135 990 1,200 1,188 1,102
Cash & Equivalents
1,050 950 948 970 925 886 831 733 747 675 691
Restricted Cash
7.80 9.38 7.80 8.50 8.50 8.50 8.50 7.61 235 280 261
Short-Term Investments
409 432 349 228 229 218 158 89 83 37 9.48
Accounts Receivable
73 82 50 78 60 73 93 122 85 126 84
Prepaid Expenses
34 29 33 27 23 24 30 24 35 38 38
Other Current Assets
11 11 20 37 28 12 14 15 16 32 18
Plant, Property, & Equipment, net
11 14 17 28 33 36 43 50 57 64 67
Total Noncurrent Assets
179 176 179 182 182 179 172 174 232 224 223
Goodwill
123 123 123 124 124 124 124 124 154 154 154
Intangible Assets
- - - 34 33 31 28 27 54 48 46
Other Noncurrent Operating Assets
55 53 56 24 26 24 21 24 24 22 23
Total Liabilities & Shareholders' Equity
1,774 1,704 1,603 1,558 1,488 1,436 1,350 1,215 1,488 1,477 1,392
Total Liabilities
341 332 308 348 346 340 362 371 649 734 677
Total Current Liabilities
326 318 297 339 338 334 357 361 637 721 662
Accounts Payable
2.98 2.82 1.71 0.92 3.69 1.03 1.55 3.44 1.52 0.79 1.16
Accrued Expenses
323 316 295 338 334 333 355 358 401 440 401
Other Current Liabilities
- - - - - - - - 234 280 260
Total Noncurrent Liabilities
14 13 11 9.11 8.06 6.61 5.39 9.86 12 13 14
Other Noncurrent Operating Liabilities
14 13 11 9.11 8.06 6.61 5.39 9.86 12 13 14
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,434 1,373 1,295 1,211 1,142 1,096 987 843 839 742 716
Total Preferred & Common Equity
1,434 1,373 1,295 1,211 1,142 1,096 987 843 839 742 716
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,434 1,373 1,295 1,211 1,142 1,096 987 843 839 742 716
Common Stock
2,108 2,104 2,082 2,073 1,886 1,866 1,794 1,650 1,648 1,547 1,513
Retained Earnings
-671 -730 -785 -861 -742 -771 -806 -807 -810 -804 -796
Accumulated Other Comprehensive Income / (Loss)
-3.18 -1.48 -1.84 -0.82 -1.27 0.83 -0.28 -0.10 1.40 -0.31 -0.61

Annual Metrics And Ratios for Marqeta

This table displays calculated financial ratios and metrics derived from Marqeta's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 102.62% 78.16% 44.67% -9.63% -25.02% 23.25%
EBITDA Growth
0.00% 21.62% -266.96% -13.06% -24.11% 118.86% -69.09%
EBIT Growth
0.00% 18.15% -245.68% -12.34% -24.71% 112.18% -147.47%
NOPAT Growth
0.00% 20.01% -244.06% -29.51% -34.89% 88.00% -36.70%
Net Income Growth
0.00% 18.05% -243.70% -12.72% -20.66% 112.24% -151.03%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
0.00% 425.86% 13.33% -122.76% 262.76% 175.64% 179.57%
Free Cash Flow Firm Growth
0.00% 0.00% -205.53% -116.97% -162.66% 96.30% 2,145.57%
Invested Capital Growth
0.00% 0.00% -59.18% -11.41% 90.72% -75.04% -1,125.78%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 6.91% -11.17% 3.46% 6.17%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 5.95% -5.75% 57.39% 186.81%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 5.97% -7.23% 109.54% 65.21%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -8.59% -0.72% 47.65% 38.55%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 5.37% -6.72% 94.48% 64.88%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 147.15% -146.77% 8.17% 16.49% 21.31%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -2.00% 67.05% 66.09%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -6.87% -50.10% -53.95% -40.67%
Profitability Metrics
- - - - - - -
Gross Margin
42.20% 40.62% 44.80% 42.77% 48.73% 69.40% 69.98%
EBITDA Margin
-38.80% -15.01% -30.91% -24.16% -33.18% 8.34% 2.09%
Operating Margin
-41.09% -16.22% -31.33% -28.04% -41.86% -4.83% -7.43%
EBIT Margin
-40.60% -16.40% -31.82% -24.71% -34.10% 5.54% -2.13%
Profit (Net Income) Margin
-40.62% -16.43% -31.70% -24.70% -32.97% 5.38% -2.23%
Tax Burden Percent
100.06% 100.18% 99.61% 99.94% 96.70% 97.18% 104.47%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 2.82% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -16.55% -17.61% -12.13% -16.42% 2.34% -1.51%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -10.40% -14.39% -10.27% -13.72% 1.84% -0.89%
Return on Assets (ROA)
0.00% -10.42% -14.33% -10.26% -13.27% 1.79% -0.93%
Return on Common Equity (ROCE)
0.00% 12.28% -12.86% -12.13% -16.42% 2.34% -1.51%
Return on Equity Simple (ROE_SIMPLE)
0.00% 22.32% -10.42% -12.54% -17.93% 2.51% 0.00%
Net Operating Profit after Tax (NOPAT)
-41 -33 -113 -147 -198 -24 -33
NOPAT Margin
-28.76% -11.35% -21.93% -19.63% -29.30% -4.69% -5.20%
Net Nonoperating Expense Percent (NNEP)
0.00% -7.79% -4.82% -2.26% -1.72% 4.31% 1.70%
Return On Investment Capital (ROIC_SIMPLE)
- - - -9.97% -15.93% -2.19% -4.27%
Cost of Revenue to Revenue
57.80% 59.38% 55.20% 57.23% 51.27% 30.60% 30.02%
SG&A Expenses to Revenue
15.40% 53.56% 12.68% 13.68% 14.09% 19.11% 17.17%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
83.28% 56.84% 76.13% 70.81% 90.59% 74.22% 77.41%
Earnings before Interest and Taxes (EBIT)
-58 -48 -165 -185 -231 28 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-56 -44 -160 -181 -224 42 13
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 5.89 2.26 2.93 1.75 2.74
Price to Tangible Book Value (P/TBV)
0.00 0.00 5.89 2.26 3.36 2.04 3.76
Price to Revenue (P/Rev)
8.57 4.23 17.93 4.45 5.39 3.76 3.35
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 69.78 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 1.43% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 4.65 14.61 2.27 3.53 1.56 1.62
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 18.75 77.30
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 28.25 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 26.87 132.65 0.00 112.98 13.64 6.22
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 23.70 0.00 0.00 0.00 0.00 3.90
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -1.31 -1.13 -1.10 -1.06 -1.02 -1.19
Leverage Ratio
0.00 1.59 1.23 1.18 1.24 1.31 1.62
Compound Leverage Factor
0.00 1.59 1.23 1.18 1.24 1.31 1.62
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 174.17% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -74.17% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 4.62 22.35 7.31 6.33 3.39 1.66
Noncontrolling Interest Sharing Ratio
0.00% 174.17% 26.96% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 3.05 7.56 6.18 4.13 3.37 1.65
Quick Ratio
0.00 2.83 7.33 5.95 3.93 3.23 1.17
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 57 -60 -131 -343 -13 259
Operating Cash Flow to CapEx
-314.34% 2,116.76% 2,077.00% -559.12% 166.82% 274.23% 537.42%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.63 0.45 0.42 0.40 0.33 0.42
Accounts Receivable Turnover
0.00 10.21 14.36 14.70 10.28 5.96 6.27
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 30.63 53.97 87.37 51.61 18.01 12.83
Accounts Payable Turnover
0.00 72.98 112.95 131.94 132.87 159.37 158.06
Days Sales Outstanding (DSO)
0.00 35.76 25.42 24.83 35.51 61.23 58.19
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 5.00 3.23 2.77 2.75 2.29 2.31
Cash Conversion Cycle (CCC)
0.00 30.76 22.19 22.07 32.77 58.94 55.88
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 -90 -143 -160 -15 -26 -318
Invested Capital Turnover
0.00 -6.45 -4.44 -4.94 -7.76 -24.91 -3.64
Increase / (Decrease) in Invested Capital
0.00 -90 -53 -16 145 -11 -292
Enterprise Value (EV)
0.00 1,351 7,558 1,698 2,384 793 1,011
Market Capitalization
1,227 1,227 9,274 3,331 3,643 1,904 2,090
Book Value per Share
$0.00 ($1.74) $2.91 $2.70 $2.38 $2.16 $1.73
Tangible Book Value per Share
$0.00 ($1.74) $2.91 $2.70 $2.08 $1.85 $1.26
Total Capital
0.00 288 1,573 1,473 1,243 1,085 762
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -378 -1,717 -1,633 -1,258 -1,111 -1,080
Capital Expenditures (CapEx)
4.91 2.38 2.74 2.32 13 21 30
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -88 -147 -169 -206 -233 -593
Debt-free Net Working Capital (DFNWC)
0.00 290 1,561 1,464 1,052 878 486
Net Working Capital (NWC)
0.00 290 1,561 1,464 1,052 878 486
Net Nonoperating Expense (NNE)
17 15 51 38 25 -51 -19
Net Nonoperating Obligations (NNO)
0.00 -378 -1,717 -1,633 -1,258 -1,111 -1,080
Total Depreciation and Amortization (D&A)
2.58 4.04 4.70 4.13 6.25 14 26
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -30.43% -28.52% -22.54% -30.48% -45.88% -94.94%
Debt-free Net Working Capital to Revenue
0.00% 99.83% 301.79% 195.65% 155.60% 173.24% 77.82%
Net Working Capital to Revenue
0.00% 99.83% 301.79% 195.65% 155.60% 173.24% 77.82%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.45) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 362.76M 545.40M 532.54M 511.07M 462.17M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 362.76M 545.40M 532.54M 518.85M 462.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 542.80M 538.58M 513.81M 504.32M 427.21M
Normalized Net Operating Profit after Tax (NOPAT)
-41 -33 -113 -147 -198 -24 -33
Normalized NOPAT Margin
-28.76% -11.35% -21.93% -19.63% -29.30% -4.69% -5.20%
Pre Tax Income Margin
-40.60% -16.40% -31.82% -24.71% -34.10% 5.54% -2.13%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -5.68% -2.90% -42.29% -85.40% 565.93% -2,810.53%

Quarterly Metrics And Ratios for Marqeta

This table displays calculated financial ratios and metrics derived from Marqeta's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 427,211,892.00 424,030,313.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 427,211,892.00 106,007,578.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.02 0.07
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-41.70% -45.72% -45.80% 17.52% 14.28% 17.89% 20.05% 27.62% 26.75% 19.22% 17.02%
EBITDA Growth
-48.81% 55.37% 312.81% 54.60% 41.45% 90.74% -95.10% 115.31% 129.19% 645.21% 196.13%
EBIT Growth
-60.14% 52.58% 303.31% 47.90% 35.45% 77.66% -100.37% 89.04% 93.50% 200.02% 1,930.39%
NOPAT Growth
-3.70% 42.98% 315.89% 39.52% 33.57% 62.81% -106.16% 75.44% 77.84% 115.75% 152.77%
Net Income Growth
-53.36% 47.59% 302.58% 47.91% 32.83% 77.09% -100.54% 87.35% 94.86% 194.84% 1,269.55%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
10.68% 104.04% 198.98% -82.29% 49.83% 2,244.37% -51.19% 1,091.69% 115.40% -133.71% 403.51%
Free Cash Flow Firm Growth
-749.07% 50.43% 159.99% 88.00% 91.81% 100.26% -138.35% 992.52% 1,994.11% 131,429.10% 752.53%
Invested Capital Growth
90.72% 110.48% -2.16% -70.65% -75.04% -377.76% 172.33% -1,241.51% -1,125.78% -2,485.23% -1,826.77%
Revenue Q/Q Growth
9.12% -0.72% 6.19% 2.15% 6.11% 2.42% 8.14% 8.59% 5.39% -3.67% 6.15%
EBITDA Q/Q Growth
32.16% 10.34% 466.74% -120.35% 12.53% 85.82% 294.05% -36.39% 66.73% 164.93% 5.40%
EBIT Q/Q Growth
24.38% 13.23% 431.95% -123.92% 6.32% 69.97% 94.50% -608.84% 44.43% 562.12% 0.56%
NOPAT Q/Q Growth
19.32% 11.51% 400.63% -128.18% 11.38% 50.47% 50.22% -12.38% 20.02% 135.20% 66.79%
Net Income Q/Q Growth
26.58% 10.69% 430.31% -124.05% 5.32% 69.54% 92.17% -460.12% 61.53% 661.98% -3.41%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-59.80% -97.42% 5,934.74% -71.68% 239.99% -59.66% 25.63% 591.54% -38.55% -106.31% 1,976.33%
Free Cash Flow Firm Q/Q Growth
2.19% 61.11% 247.06% -121.45% 33.21% 101.22% -22,002.17% 599.32% 41.75% -15.15% 8.66%
Invested Capital Q/Q Growth
-50.10% 123.54% -665.10% 14.53% -53.95% 62.65% 247.15% -1,685.32% -40.67% 21.22% 1.71%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
70.05% 71.34% 63.35% 70.43% 72.32% 70.95% 69.19% 70.15% 69.71% 70.92% 69.25%
EBITDA Margin
-31.32% -28.28% 97.68% -19.46% -16.04% -2.22% 3.99% 2.34% 3.69% 10.16% 10.09%
Operating Margin
-47.41% -42.26% 83.85% -33.00% -27.56% -13.33% -6.14% -6.35% -4.82% 1.26% 2.07%
EBIT Margin
-34.84% -30.45% 95.20% -22.29% -19.68% -5.77% -0.29% -1.91% -1.01% 4.84% 4.59%
Profit (Net Income) Margin
-33.98% -30.57% 95.08% -22.38% -19.97% -5.94% -0.43% -2.22% -0.81% 4.73% 4.30%
Tax Burden Percent
97.51% 100.37% 99.87% 100.40% 101.47% 102.93% 146.71% 115.93% 80.25% 97.60% 93.74%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.40% 6.26%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-16.42% -14.39% -0.98% 1.17% 2.34% 5.01% -6.51% -4.10% -1.51% 0.25% 1.33%
Cash Return on Invested Capital (CROIC)
0.00% -5,985.27% 0.00% 0.00% 0.00% 0.00% -766.32% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-14.02% -10.54% 28.09% -7.19% -6.54% -2.10% -0.12% -0.77% -0.42% 2.23% 2.38%
Return on Assets (ROA)
-13.68% -10.58% 28.05% -7.22% -6.63% -2.16% -0.18% -0.89% -0.34% 2.18% 2.23%
Return on Common Equity (ROCE)
-16.42% -14.39% -0.98% 1.17% 2.34% 5.01% -6.51% -4.10% -1.51% 0.25% 1.33%
Return on Equity Simple (ROE_SIMPLE)
0.00% -15.71% -1.08% 1.28% 0.00% 5.58% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-39 -35 105 -30 -26 -13 -6.46 -7.26 -5.81 2.04 3.41
NOPAT Margin
-33.19% -29.58% 83.75% -23.10% -19.29% -9.33% -4.30% -4.45% -3.37% 1.23% 1.94%
Net Nonoperating Expense Percent (NNEP)
-0.07% -0.09% 1.11% 0.08% -0.08% 0.43% 0.58% 0.33% 0.40% 0.58% 0.46%
Return On Investment Capital (ROIC_SIMPLE)
-3.17% - - - -2.41% -1.31% -0.77% -0.87% -0.76% 0.28% 0.48%
Cost of Revenue to Revenue
-65.59% 28.66% 119.01% 29.57% -48.29% 29.05% 30.81% 29.85% 30.29% 29.08% 30.75%
SG&A Expenses to Revenue
20.97% 17.71% 18.36% 19.69% 20.49% 17.58% 15.74% 19.03% 16.31% 15.85% 16.20%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
213.00% 113.60% -102.86% 103.44% 175.86% 84.28% 75.33% 76.50% 74.53% 69.66% 67.18%
Earnings before Interest and Taxes (EBIT)
-41 -36 119 -29 -27 -8.03 -0.44 -3.13 -1.74 8.03 8.07
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-37 -33 122 -25 -22 -3.09 6.00 3.81 6.36 17 18
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.93 2.53 2.49 2.28 1.75 2.10 3.24 2.82 2.74 2.35 2.41
Price to Tangible Book Value (P/TBV)
3.36 2.91 2.88 2.66 2.04 2.49 3.94 3.75 3.76 3.23 3.34
Price to Revenue (P/Rev)
5.39 5.31 6.03 5.10 3.76 3.93 4.93 4.02 3.35 2.68 2.54
Price to Earnings (P/E)
0.00 0.00 0.00 178.26 69.78 37.72 0.00 0.00 0.00 803.61 165.81
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.56% 1.43% 2.65% 0.00% 0.00% 0.00% 0.12% 0.60%
Enterprise Value to Invested Capital (EV/IC)
0.00 532.47 0.00 0.00 0.00 0.00 133.48 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
3.53 3.22 3.56 2.83 1.56 2.05 3.44 2.21 1.62 1.15 1.12
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 51.66 18.75 14.89 0.00 0.00 77.30 22.73 16.98
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 103.63 28.25 19.31 0.00 0.00 0.00 275.64 67.65
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 160.40 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
112.98 57.84 20.02 27.81 13.64 15.96 34.83 9.71 6.22 5.03 3.80
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 54.32 0.00 8.34 3.90 3.41 3.06
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.06 -1.01 -1.02 -1.01 -1.02 -1.00 -1.00 -1.13 -1.19 -1.15 -1.15
Leverage Ratio
1.24 1.26 1.27 1.27 1.31 1.32 1.36 1.51 1.62 1.63 1.67
Compound Leverage Factor
1.24 1.26 1.27 1.27 1.31 1.32 1.36 1.51 1.62 1.63 1.67
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
6.72 5.58 5.56 4.68 3.26 3.67 4.56 2.27 1.69 1.50 1.61
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.13 3.98 3.77 3.66 3.37 3.18 2.74 1.88 1.65 1.65 1.66
Quick Ratio
3.93 3.77 3.59 3.53 3.23 3.03 2.61 1.44 1.17 1.16 1.19
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-184 -72 105 -23 -15 0.18 -40 202 286 243 264
Operating Cash Flow to CapEx
676.85% 6.56% 416.93% 169.52% 582.06% 136.34% 159.35% 1,050.07% 784.38% -37.09% 737.69%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.40 0.35 0.30 0.32 0.33 0.36 0.41 0.40 0.42 0.46 0.52
Accounts Receivable Turnover
10.28 7.64 6.61 7.95 5.96 6.18 6.07 7.45 6.27 5.95 6.57
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
51.61 29.73 19.90 18.56 18.01 14.94 13.29 12.75 12.83 12.24 11.55
Accounts Payable Turnover
132.87 129.48 43.47 104.50 159.37 131.17 16.56 54.91 158.06 167.10 88.32
Days Sales Outstanding (DSO)
35.51 47.76 55.20 45.91 61.23 59.10 60.17 48.97 58.19 61.37 55.57
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
2.75 2.82 8.40 3.49 2.29 2.78 22.05 6.65 2.31 2.18 4.13
Cash Conversion Cycle (CCC)
32.77 44.94 46.80 42.42 58.94 56.32 38.12 42.32 55.88 59.19 51.44
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-15 3.48 -20 -17 -26 -9.68 14 -226 -318 -250 -246
Invested Capital Turnover
-7.76 -38.77 -24.18 -36.72 -24.91 -170.55 -203.09 -4.85 -3.64 -5.02 -5.85
Increase / (Decrease) in Invested Capital
145 37 -0.42 -6.97 -11 -13 34 -209 -292 -240 -260
Enterprise Value (EV)
2,384 1,855 1,677 1,389 793 1,081 1,901 1,302 1,011 751 760
Market Capitalization
3,643 3,062 2,839 2,501 1,904 2,078 2,730 2,367 2,090 1,743 1,722
Book Value per Share
$2.38 $2.36 $2.20 $2.16 $2.16 $1.96 $1.80 $1.87 $1.73 $1.74 $1.69
Tangible Book Value per Share
$2.08 $2.05 $1.90 $1.85 $1.85 $1.66 $1.48 $1.41 $1.26 $1.26 $1.22
Total Capital
1,243 1,211 1,142 1,096 1,085 987 843 839 762 742 716
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-1,258 -1,207 -1,162 -1,112 -1,111 -997 -829 -1,065 -1,080 -992 -961
Capital Expenditures (CapEx)
2.44 6.50 6.17 4.30 4.25 7.33 7.87 8.26 6.80 9.08 8.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-206 -198 -227 -225 -233 -219 -200 -502 -593 -525 -522
Debt-free Net Working Capital (DFNWC)
1,052 1,010 935 888 878 778 629 563 486 467 440
Net Working Capital (NWC)
1,052 1,010 935 888 878 778 629 563 486 467 440
Net Nonoperating Expense (NNE)
0.94 1.16 -14 -0.92 0.92 -4.72 -5.81 -3.64 -4.41 -5.79 -4.16
Net Nonoperating Obligations (NNO)
-1,258 -1,207 -1,162 -1,112 -1,111 -997 -829 -1,065 -1,080 -992 -961
Total Depreciation and Amortization (D&A)
4.19 2.56 3.11 3.62 4.94 4.94 6.44 6.94 8.10 8.82 9.68
Debt-free, Cash-free Net Working Capital to Revenue
-30.48% -34.26% -48.20% -45.89% -45.88% -41.52% -36.20% -85.25% -94.94% -80.60% -77.03%
Debt-free Net Working Capital to Revenue
155.60% 175.03% 198.55% 181.13% 173.24% 147.26% 113.69% 95.70% 77.82% 71.71% 64.94%
Net Working Capital to Revenue
155.60% 175.03% 198.55% 181.13% 173.24% 147.26% 113.69% 95.70% 77.82% 71.71% 64.94%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
532.54M 517.99M 515.96M 507.16M 511.07M 501.22M 461.52M 448.72M 462.17M 428.60M 105.47M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
532.54M 517.99M 524.40M 507.16M 518.85M 501.22M 461.52M 448.72M 462.17M 433.57M 106.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
513.81M 518.11M 508.37M 502.39M 504.32M 468.27M 448.23M 440.10M 427.21M 424.03M 104.10M
Normalized Net Operating Profit after Tax (NOPAT)
-39 -35 105 -30 -26 -13 -6.46 -7.26 -5.81 2.04 3.41
Normalized NOPAT Margin
-33.19% -29.58% 83.75% -23.10% -19.29% -9.33% -4.30% -4.45% -3.37% 1.23% 1.94%
Pre Tax Income Margin
-34.84% -30.45% 95.20% -22.29% -19.68% -5.77% -0.29% -1.91% -1.01% 4.84% 4.59%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-85.40% -106.33% -1,741.71% 1,401.32% 565.93% 421.26% -523.44% -785.63% -2,810.53% 14,719.36% 2,022.66%

Financials Breakdown Chart

Key Financial Trends

Marqeta’s latest results show a meaningful improvement in operating performance. Revenue increased to $176.0 million in Q2 2026, up from $165.8 million in Q1 2026 and $150.4 million in the restated Q2 2025. The longer-term trend is also favorable compared with the unusually weak revenue levels reported during parts of 2023 and early 2024. Gross profit reached $121.9 million, producing a gross margin of approximately 69.2%, broadly consistent with Q2 2025.

Profitability has improved sharply. Marqeta generated $3.6 million of operating income and $7.6 million of net income in Q2 2026, following $2.1 million of operating income and $7.8 million of net income in Q1. This compares with operating losses in every listed quarter from Q3 2022 through Q4 2025, except for the unusual Q2 2024 restated figures. However, Q2’s net income benefited from $4.4 million of other income, so investors should continue watching whether operating profits expand without relying on investment or other non-operating gains.

Cash generation was another strong point in the latest quarter. Operating cash flow improved to $63.2 million in Q2 2026 from an outflow of $3.4 million in Q1, although the result was helped substantially by a $45.2 million favorable change in operating assets and liabilities. Marqeta spent $54.7 million repurchasing common stock and $30.6 million on other financing activities, resulting in a modest $2.0 million decline in cash and equivalents during the quarter.

The balance sheet remains liquid but has weakened from 2023 and 2024 levels. Cash, restricted cash and short-term investments totaled approximately $961.4 million at June 30, 2026, while total liabilities were $676.7 million. Total assets declined to $1.39 billion from $1.49 billion in Q1 2026 and $1.49 billion in Q3 2025. Accrued expenses and other current liabilities remain sizable, and retained earnings are still negative at approximately $796.4 million. The supplied statements also include several restated periods and a sharp change in reported weighted-average shares, so investors should verify the effects of any reverse split or other corporate action before comparing per-share metrics.

  • Revenue momentum has returned: Q2 2026 revenue rose approximately 17% year over year from the restated Q2 2025 figure and was up about 48% from Q3 2022.
  • Marqeta reached operating profitability: Operating income improved to $3.6 million in Q2 2026 after a $1.4 million operating loss in Q4 2025.
  • Net income was positive for a second consecutive quarter: Q2 2026 net income was $7.6 million, compared with losses in the listed quarters from Q3 2022 through Q4 2025.
  • Gross margins remain strong: The Q2 2026 gross margin was approximately 69%, well above the 42% reported in Q3 2022 and similar to the restated Q2 2025 margin.
  • Operating cash flow rebounded: Cash flow from operations increased to $63.2 million in Q2 2026 from negative $3.4 million in Q1 2026.
  • Debt levels appear limited: The supplied balance sheets show no significant traditional long-term debt, with noncurrent operating liabilities of only $14.4 million at June 30, 2026.
  • Liquidity remains substantial but includes restricted funds: Cash, restricted cash and short-term investments totaled about $961.4 million, but $260.6 million was classified as restricted cash and may not be freely available for general corporate use.
  • Cash flow has been volatile: Operating cash flow was positive in most listed quarters but turned negative in Q1 2026, while investing cash flow often depended on sales or maturities of investments rather than recurring operating activity.
  • Share repurchases are consuming cash: Marqeta repurchased $54.7 million of stock in Q2 2026, following $39.2 million in Q1 and $96.6 million in Q4 2025, despite still-negative retained earnings.
  • Balance-sheet equity has declined: Total equity fell to $715.6 million in Q2 2026 from $1.21 billion in Q1 2024, while total liabilities increased substantially from $345.9 million in Q2 2024 to $676.7 million.
09/13/26 03:35 AM ETAI Generated. May Contain Errors.

Marqeta Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Marqeta's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Marqeta's net income appears to be on a downward trend, with a most recent value of -$13.93 million in 2025, falling from -$58.20 million in 2019. The previous period was $27.29 million in 2024. See Marqeta's forecast for analyst expectations on what's next for the company.

Marqeta's total operating income in 2025 was -$46.43 million, based on the following breakdown:
  • Total Gross Profit: $437.27 million
  • Total Operating Expenses: $483.70 million

Over the last 6 years, Marqeta's total revenue changed from $143.27 million in 2019 to $624.88 million in 2025, a change of 336.2%.

Marqeta's total liabilities were at $763.08 million at the end of 2025, a 101.8% increase from 2024, and a 350.1% increase since 2020.

In the past 5 years, Marqeta's cash and equivalents has ranged from $220.43 million in 2020 to $1.25 billion in 2021, and is currently $709.44 million as of their latest financial filing in 2025.

Over the last 6 years, Marqeta's book value per share changed from 0.00 in 2019 to 1.73 in 2025, a change of 173.1%.



Financial statements for NASDAQ:MQ last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners